Direct-to-consumer advertising under the radar: The need for realistic drugs policy in Australia

Internal Medicine Journal

Volumn 37, Issue 4, 2007, Pages 224-228

  Mackenzie, F J ^a   Jordens, C F C ^a   Ankeny, R A ^a,b   McPhee, J ^a   Kerridge, I H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Advertising; Australian health policy; Drug; Drug industry; Health care cost; Prescription

Indexed keywords

SILDENAFIL;

ADVERTIZING; AUSTRALIA; DRUG APPROVAL; DRUG MARKETING; ERECTILE DYSFUNCTION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; INTERNET; LAW; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TELECOMMUNICATION;

ADVERTISING; AUSTRALIA; DECISION MAKING; DRUG INDUSTRY; HEALTH POLICY; HUMANS; INFORMATION DISSEMINATION; PATIENT PARTICIPATION;

EID: 33947398373     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01298.x     Document Type: Review

References (36)

1. Doran E, Robertson J, Henry D. Moral hazard and prescription medicine use in Australia - the patient perspective. Soc Sci Med 2005; 60: 1437-43.
2. Duckett S. Drug policy down under: Australia's Pharmaceutical Benefits Scheme. Health Care Financ Rev 2004; 25: 55-67.
3. Moynihan R, Cassels A. Selling Sickness: How the World's Biggest Pharmaceutical Companies are Turning us All into Patients. New York: Nations Books; 2005.
4. Wilde A. Disorders for all. The Sydney Morning Herald 2005 July 21;Sect. 3.
5. WHO Department of Essential Drugs and Medicines Policy; Health Action International Europe; Mansfield P, Mintzes B, Medawa C. DTCA and consumers' decisions. Database DP [page on the Internet] 2002 [cited 2006 Mar 23]. Available from URL: http://www.drugpromo.info/read-reviews.asp?id=4
6. Lexchin J. Direct-to-consumer advertising: impact on patient expectations regarding disease management. Dis Manag Health Outcomes 1999; 5: 273-83.
7. Mintzes B, Barer M, Kravitz R, Kazanjian A, Bassett K, Lexchin J et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ 2002; 324: 278-9.
8. Rosenthal M, Berndt E, Donohue J, Epstein R, Frank R. Demand Effects of Recent Changes in Prescription Drug Promotion. Washington: Kaiser Family Foundation; 2003.
9. Cresswell A. Drug companies' tactics sidestep direct advertising ban. The Weekend Australian 2005 May 14.
10. Mintzes B. Blurring the Boundaries: New Trends in Drug Promotion. Amsterdam: Health Action International Europe; 1998.
11. Moynihan R. Blurring the boundaries. BMJ 2003; 326: 1094.
12. Cohen D, McCubbin M, Collin J, Peródeau G. Medications as social phenomena. Health 2001; 5: 441-69.
13. Gilbert D, Chetley A. New trends in drug promotion. Consumer Policy Rev 1996; 6: 162-7.
14. Herxheimer A. Relationships between the pharmaceutical industry and patients' organisations. BMJ 2003; 326: 1208-10.
15. Goldsmith J. How will the Internet change our health system? Health Aff (Millwood) 2000; 19: 148-56.
16. Zoloft.com. Zoloft.com [homepage on the Internet] [cited 2006 Mar 21]. Available from URL: http://www.zoloft.com/zoloft/zoloft.portal?_nfpb= true&_pageLabel=default_home
17. WebMD. WebMD [homepage on the Internet] [cited 2006 Mar 21]. Available from URL: http://www.webmd.com/content/article/10/1663_51222.htm
18. Jensen U, Mooney G. Changing values: autonomy and paternalism in medicine and health care. In: Jensen U, Mooney G, eds. Changing Values in Medical and Health Care Decision Making. Chichester: John Wiley; 1990: 1-16.
19. Coulter A. Information for shared decision-making in medicine-taking. In: Mintzes B, ed. Providing Prescription Medicine Information to Consumers: Is There a Role For Direct-To-Consumer Promotion? Brussels: Health Action International Europe; 2002; 20-23.
20. Department of Health and Ageing. Consumer medicine information. HealthInsite [homepage on the Internet] 2005 Sept 12 [cited 2006 Mar 23]. Available from URL: http://www.healthinsite.gov.au/content/internal/page.cfm? ObjID=00027679-144D-1325-813683978677006D
21. National Prescribing Service Limited. NPS website [homepage on the Internet] [cited 2006 Mar 23]. Available from URL: http://www.nps.org.au
22. National Asthma Council Australia. National Asthma Council Australia website [homepage on the Internet] [cited 2006 Mar 23]. Available from URL: http://www.nationalasthma.org.au
23. Ager B. The pharmaceutical industry's perspective on providing prescription drug information directly to EU consumers. In: Mintzes B, ed. Providing Prescription Medicine Information to Consumers: Is There a Role For Direct-To-Consumer Promotion? Brussels: Health Action International Europe; 2002; 30-32.
24. HealthCentral. HealthCentral [homepage on the Internet] [cited 2006 Mar 23]. Available from URL: http://scc.healthcentral.com/bcp/main.asp?ap= 416&brand= 28&page=adam&id=003164trt
25. Orr G, Weiser M, Polliack M, Raviv G, Tadmor D, Grunhaus L. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a double-blind, placebo-controlled crossover study. J Clin Psychopharmacol 2006; 26: 426-30.
26. Sharma R, Prasad N, Gupta A, Kapoor R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double-blind, placebo-controlled, crossover trial. Am J Kidney Dis 2006; 48: 128-33.
27. Althof S, O'leary M, Cappelleri J, Hvidsten K, Stecher V, Glina S et al. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: results from an international, multi-center, placebo-controlled trial. J Sex Med 2006; 3: 521-9.
28. Fowler C, Miller J, Sharief M, Hussain I, Stecher V, Sweeney M. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 700-705.
29. Stuckey B, Jadzinsky M, Murphy L, Montorsi F, Kadioglu A, Fraige F et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003; 26: 279-84.
30. Eggins S. Genre: context of culture in text. In: Eggins S. An Introduction to Systemic Functional Linguistics, 2nd edn. London, New York: Continuum; 2004; 54-82.
31. Goleman D. Vital Lies, Simple Truths: The Psychology of self-Deception. London: Bloomsbury; 1997.
32. Toop L, Richards D, Dowell T, Tilyard M, Fraser T, Arroll B. Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit. Report to the Minister for Health supporting the case for a ban on DTCA. Christchurch, Dunedin, Wellington, Auckland: New Zealand Departments of General Practice; 2003.
33. Smith R. Curbing the influence of the drug industry: a British view. Public Library of Science-Medicine [serial on the Internet] 2005 [cited 2006 Mar 23]. Available from URL: http://medicine.plosjournals.org/perlserv/?request= get-document&doi=10.1371/journal.pmed.0020241
34. Burgess V. Pharmaceutical body worth the wait. Australian Financial Review 2005 April 29;Sect. 67.
35. Metherell M. Patients to have bigger say on drug rules. The Sydney Morning Herald [newspaper on the Internet] 2006 Jan 11 [cited 2006 Mar 23]. Available from URL: http://www.smh.com.au/news/national/patients-to-have-bigger- say-on-drug-rules/2006/01/10/1136863239601.html
36. Ruff T, Haikal-Mukhtar H. Doctors, drugs, information and ethics: a never-ending story. Med J Aust 2005; 183: 73-4.